According to China stock market news choice, seven new shares rose by an average of 22.69% on the first day of listing this week. Among them, the tender shares rose 128.14% on the first day; The single signature profit of chuangyao technology exceeded 10000 yuan.
Among the new shares that can be subscribed next week, Jingke energy, which is to be subscribed on Monday, is a world-famous manufacturer of photovoltaic products. According to the prospectus, the company’s PV module shipments ranked first in the world for four consecutive years from 2016 to 2019 and second in the world in 2020.
From the perspective of strategic placement, among the 14 allocated strategic investors, including social security fund, China Life Insurance Company Limited(601628) , Taiping Life Insurance, Shenzhen Venture Capital and other well-known institutions.
It is worth mentioning that the online subscription limit of Jingke energy is 280000 shares. Generally speaking, the higher the online subscription limit, the higher the success rate of new shares and the greater the chance of success.
review: new shares broke frequently this week
This week (from January 10 to January 14), three of the seven new shares broke on the first day of listing.
from the issue price, the issue price of two new shares was lower than 30 yuan, with a high increase on the first day of listing. They are tender shares and temus, up 128.14% and 43.98% respectively on the first day (weekly increase of 91.65%). Among the four new shares with an issue price of more than 30 yuan, three suffered a break. Among them, the single signing loss of new shares with the highest issuance price was nearly 30000 yuan.
in terms of the initial P / E ratio, chuangyao technology’s corresponding static PE was higher, 83.65 times, but it still rose 32.36% on the first day of listing.
Outlook: list of fundamentals of new shares next week
according to the current arrangement, if there is no change, there will be 8 new shares available for subscription next week (January 17 to January 21), including 3 on the science and innovation board and 5 on the gem.
Monday
Jingke energy:
The company is a world-famous manufacturer of photovoltaic products with photovoltaic industry technology as the core. At this stage, the company is mainly engaged in the R & D, production and sales of Cecep Solar Energy Co.Ltd(000591) photovoltaic modules, cells and silicon chips, as well as the application and industrialization of photovoltaic technology.
Corresponding PE * adopts the caliber of “diluted P / E ratio before and after deducting non recurring profits and losses in 2020, whichever is lower”, the same below
Comparable PE * adopts “static non front” caliber, the same below
Jingke energy expects a net profit of 830 million yuan to 870 million yuan in 2021.
adopted shares:
The company is mainly engaged in the R & D, production and sales of injection and puncture instruments and laboratory consumables, and provides puncture needles, syringes, laboratory consumables and other related products to world-famous enterprises through ODM / OEM.
The net profit of the adopted shares is expected to be 109 million yuan to 126 million yuan in 2021. After excluding the impact of mask business in 2020, the net profit is expected to increase by 184.69% to 229.08%. Adoptive shares said that the company’s product registration with FDA in the United States has increased, and new products have been launched continuously, and the revenue of syringe products will rise sharply.
Tuesday
Juncheng Technology:
The company focuses on the field of liquid crystal display, mainly engaged in the R & D, design, production and sales of customized liquid crystal display products.
Juncheng technology expects the net profit in 2021 to be 78.0616 million yuan to 81.8038 million yuan, an increase of 21.38% to 27.20% over the previous year.
Copper Crown copper foil:
The company is mainly engaged in the R & D, manufacturing and sales of all kinds of high-precision electronic copper foil. The main products are classified according to application fields, including PCB copper foil and lithium battery copper foil.
The net profit of Tongguan copper foil is expected to be 349 million yuan in 2021, an increase of 387.26% over the previous year. According to the prospectus, the company’s performance increased significantly in the first three quarters of 2021. On the one hand, due to the covid-19 epidemic and industry fluctuations, the performance in the first half of 2020 was at a historical low; On the other hand, the strong demand for products and the corresponding rise in processing fees led to the recovery of performance.
Weide information:
The company is a technologically innovative information security enterprise, committed to providing independent, controllable, safe and reliable information security products and services for industrial enterprises.
Weide information predicts that the net profit in 2021 will be 55 million yuan to 65 million yuan, a decrease of 13.61% to an increase of 2.09% over the previous year.
radium Technology:
The company focuses on the R & D, production and sales of integrated circuit chips and Microsystems, and provides technical services around related products. The company has become one of the core suppliers of RF chips and power management chips in the field of military communication and radar in China.
The net profit of Zhenlei technology is expected to be 85 million yuan to 100 million yuan in 2021, an increase of 10.48% to 29.98% over the previous year.
Wednesday
real estate detection:
The company is a third-party testing organization specializing in soil and groundwater. The testing scope includes soil, water quality, gas, solid waste, Shenzhen Agricultural Products Group Co.Ltd(000061) food and dioxin, covering testing businesses related to environment and food safety from farmland to dining table.
It is estimated that the net profit of Shipu testing will be 47 million yuan to 57 million yuan in 2021, a decrease of 1.71% to an increase of 19.20% over the previous year; The net profit after deducting non-profit was 46 million yuan to 56 million yuan, an increase of 7.70% to 31.12% over the previous year.
Huakang medical:
The company is a comprehensive service provider of modern medical purification system, which is committed to solving the problem of medical infection and providing a clean, safe and intelligent medical environment for all kinds of hospitals. Its main business includes the R & D, design, implementation and operation and maintenance of medical purification system, and the sales of relevant medical equipment and medical consumables.
Huakang medical expects its net profit to be 73 million yuan to 82 million yuan in 2021, an increase of 39.51% to 54.15% over the previous year.
